Publications by authors named "Solo Goldstein"

Claim this Profile
P
Productive Syntheses of Privileged Scaffolds Inspired by the Recognition of a Diels-Alder Pattern Common to Three Classes of Natural Products.
Eduard Badarau, K Harsha Vardhan Reddy, Aurore Loudet, Charles Simon, Laurent Trembleau, Solo Goldstein

Chemistry· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice.
Frédéric De Ceuninck, Catherine Kargar, Yves Charton, Solo Goldstein, Françoise Perron-Sierra

Br J Pharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of thieno[2,3-b]pyridine derivatives as novel c-Src inhibitors.
Isabelle Pevet, Cédric Brulé, André Tizot, Arnaud Gohier, Francisco Cruzalegui, Solo Goldstein

Bioorg Med Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and affinity profile of novel nicotinic ligands.
Yves Charton, Claude Guillonneau, Brian Lockhart, Pierre Lestage, Solo Goldstein

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical trapping properties of imidazolyl nitrones.
Karine Reybier, Jeremie Boyer, Vincent Farines, Fabrice Camus, Jean-Pierre Souchard, Solo Goldstein

Free Radic Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176).
Brian Lockhart, Anita Roger, Norbert Bonhomme, Solo Goldstein, Pierre Lestage

Eur J Pharmacol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic and antitumoral properties in a series of new, ring D modified, olivacine analogues.
Claude Guillonneau, Annette Nault, Eric Raimbaud, Stéphane Léonce, Laurence Kraus-Berthier, Solo Goldstein

Bioorg Med Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidants.
Claude Guillonneau, Yves Charton, Yves-Michel Ginot, Marie-Victoire Fouquier-d'Hérouël, Marc Bertrand, Solo Goldstein

Eur J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Laurence Kraus-Berthier, Nicolas Guilbaud, Stéphane Léonce, Tracy Parker, Patrick Genissel, Solo Goldstein

Cancer Chemother Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Didier Cussac, Adrian Newman-Tancredi, Yann Quentric, Nathalie Carpentier, Guillaume Poissonnet, Solo Goldstein

Naunyn Schmiedebergs Arch Pharmacol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis